评价文献:Peters S, Camidge DR, Shaw AT, et al. Alectinib versus Crizotinib in untreated ALK-positive non-small-cell lung cancer[J]. N Eng J Med, 2017, 377(9):829-83...|阅读全文
Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program.Illini O,...|阅读全文